Cargando…
PCM and TAT co-modified liposome with improved myocardium delivery: in vitro and in vivo evaluations
In this study, PCM and TAT co-modified liposome was developed as a novel drug carrier for myocardium delivery with evaluation of its in vitro and in vivo properties. Liposomes containing fluorescent probe coumarin-6 were prepared by thin-film hydration. The PCM ligands specifically bind to the PCM r...
Autores principales: | Wang, Xin, Huang, Hua, Zhang, Liangke, Bai, Yan, Chen, Huali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241121/ https://www.ncbi.nlm.nih.gov/pubmed/28165817 http://dx.doi.org/10.1080/10717544.2016.1253121 |
Ejemplares similares
-
In vitro and in vivo evaluation of liposomes modified with polypeptides and red cell membrane as a novel drug delivery system for myocardium targeting
por: Liu, Xueyan, et al.
Publicado: (2020) -
Preparation and evaluation of RGD and TAT co-modified docetaxel-loaded liposome
por: Zhu, Ren, et al.
Publicado: (2017) -
Regulation of in vivo behavior of TAT-modified liposome by associated protein corona and avidity to tumor cells
por: Amin, Mohamadreza, et al.
Publicado: (2018) -
Tat-functionalized liposomes for the treatment of meningitis: an in vitro study
por: Bartomeu Garcia, Caterina, et al.
Publicado: (2017) -
Tat-Functionalized Liposomes for the Treatment of Meningitis: An in vitro Study [Corrigendum]
Publicado: (2020)